164 related articles for article (PubMed ID: 26086231)
21. Retrospective evaluation of the effect of trilostane on insulin requirement and fructosamine concentration in eight diabetic dogs with hyperadrenocorticism.
McLauchlan G; Knottenbelt C; Augusto M; Helm J; McGrotty Y; Ramsey I
J Small Anim Pract; 2010 Dec; 51(12):642-8. PubMed ID: 21121919
[TBL] [Abstract][Full Text] [Related]
22. Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs.
Hulsebosch SE; Pires J; Bannasch MJ; Lancaster T; Delpero A; Ragupathy R; Murikipudi S; Zion T; Gilor C
J Vet Intern Med; 2022 Jul; 36(4):1211-1219. PubMed ID: 35621084
[TBL] [Abstract][Full Text] [Related]
23. [Prospective observational study of insulin detemir in patients with poorly controlled type 2 diabetes mellitus initiating insulin therapy for the first time (SOLVE Study)].
Orozco-Beltrán D; Artola-Menéndez S
Aten Primaria; 2016 Feb; 48(2):95-101. PubMed ID: 26054893
[TBL] [Abstract][Full Text] [Related]
24. Field safety and efficacy of protamine zinc recombinant human insulin for treatment of diabetes mellitus in cats.
Nelson RW; Henley K; Cole C;
J Vet Intern Med; 2009; 23(4):787-93. PubMed ID: 19566845
[TBL] [Abstract][Full Text] [Related]
25. Effect of subcutaneous insulin detemir on glucose flux, lipolysis and electroencephalography in type 1 diabetes.
Herring R; Knight R; Shojaee-Moradie F; Johnsen S; Umpleby AM; Jackson N; Jones R; Dijk DJ; Russell-Jones DL
Diabetes Obes Metab; 2015 Nov; 17(11):1100-3. PubMed ID: 26272173
[TBL] [Abstract][Full Text] [Related]
26. Insulin glargine 300 U/ml for the treatment of feline diabetes mellitus.
Linari G; Fleeman L; Gilor C; Giacomelli L; Fracassi F
J Feline Med Surg; 2022 Feb; 24(2):168-176. PubMed ID: 34009061
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of dosing and clinical outcomes in patients undergoing conversion of insulin glargine to insulin detemir.
Bryant GA; McDanel DL; Horner KE; Farris KB; Newkirk EN
Pharmacotherapy; 2013 Jan; 33(1):56-62. PubMed ID: 23307546
[TBL] [Abstract][Full Text] [Related]
28. Insulin-induced hyperglycemia in diabetic dogs.
Feldman EC; Nelson RW
J Am Vet Med Assoc; 1982 Jun; 180(12):1432-7. PubMed ID: 7047478
[TBL] [Abstract][Full Text] [Related]
29. Treatment of feline diabetes mellitus using an alpha-glucosidase inhibitor and a low-carbohydrate diet.
Mazzaferro EM; Greco DS; Turner AS; Fettman MJ
J Feline Med Surg; 2003 Jun; 5(3):183-9. PubMed ID: 12765629
[TBL] [Abstract][Full Text] [Related]
30. Day-to-day variability of blood glucose concentration curves generated at home in cats with diabetes mellitus.
Alt N; Kley S; Haessig M; Reusch CE
J Am Vet Med Assoc; 2007 Apr; 230(7):1011-7. PubMed ID: 17397339
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of an insulin zinc suspension for control of naturally occurring diabetes mellitus in dogs.
Horn B; Mitten RW
Aust Vet J; 2000 Dec; 78(12):831-4. PubMed ID: 11194469
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.
Dornhorst A; Lüddeke HJ; Sreenan S; Koenen C; Hansen JB; Tsur A; Landstedt-Hallin L
Int J Clin Pract; 2007 Mar; 61(3):523-8. PubMed ID: 17313628
[TBL] [Abstract][Full Text] [Related]
33. Lack of advantage of high-fibre, moderate-carbohydrate diets in dogs with stabilised diabetes.
Fleeman LM; Rand JS; Markwell PJ
J Small Anim Pract; 2009 Nov; 50(11):604-14. PubMed ID: 19814767
[TBL] [Abstract][Full Text] [Related]
34. Effect of sodium-glucose cotransporter 2 inhibitor canagliflozin on interstitial glucose concentration in insulin-treated diabetic dogs.
Box JR; Oyama MA; Mosenco AS; Hess RS
J Vet Intern Med; 2024; 38(3):1353-1358. PubMed ID: 38528660
[TBL] [Abstract][Full Text] [Related]
35. Acid-base and hormonal abnormalities in dogs with naturally occurring diabetes mellitus.
Durocher LL; Hinchcliff KW; DiBartola SP; Johnson SE
J Am Vet Med Assoc; 2008 May; 232(9):1310-20. PubMed ID: 18447775
[TBL] [Abstract][Full Text] [Related]
36. Insulin detemir treatment in diabetic cats in a practice setting.
Hoelmkjaer KM; Spodsberg EM; Bjornvad CR
J Feline Med Surg; 2015 Feb; 17(2):144-51. PubMed ID: 24938314
[TBL] [Abstract][Full Text] [Related]
37. Insulin resistance in three dogs with hypothyroidism and diabetes mellitus.
Ford SL; Nelson RW; Feldman EC; Niwa D
J Am Vet Med Assoc; 1993 May; 202(9):1478-80. PubMed ID: 8496104
[TBL] [Abstract][Full Text] [Related]
38. Glucagon stimulation test for estimating endogenous insulin secretion in dogs.
Fall T; Holm B; Karlsson A; Ahlgren KM; Kämpe O; von Euler H
Vet Rec; 2008 Aug; 163(9):266-70. PubMed ID: 18757903
[TBL] [Abstract][Full Text] [Related]
39. Use of lispro insulin for treatment of diabetic ketoacidosis in dogs.
Sears KW; Drobatz KJ; Hess RS
J Vet Emerg Crit Care (San Antonio); 2012 Apr; 22(2):211-8. PubMed ID: 22390184
[TBL] [Abstract][Full Text] [Related]
40. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes.
Haak T; Tiengo A; Draeger E; Suntum M; Waldhäusl W
Diabetes Obes Metab; 2005 Jan; 7(1):56-64. PubMed ID: 15642076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
